Safety and efficacy of allogenic placental mesenchymal stem cells for treating knee osteoarthritis: a pilot study
ConclusionSingle intra-articular allogenic placental MSC injection in knee OA is safe and can result in clinical improvements in 24 weeks follow-up. Trial registration number: IRCT2015101823298N.
Source: Cytotherapy - Category: Cytology Source Type: research
More News: Clinical Trials | Cytology | Laboratory Medicine | Men | Osteoarthritis | Pain | Sports Medicine | Statistics | Stem Cell Therapy | Stem Cells | Study